Clinical Trials Browser

Phase 3 × Uterine Cervical Dysplasia × AKAP13 protein, human × Clear all

NCT00929526 2016-10-20

Extension Study of the Efficacy of the GSK 580299 Vaccine in Japanese Women Vaccinated in the Primary NCT00316693 Study

Phase 3 Completed

752 enrolled 21 charts

Uterine Cervical Dysplasia, Papillomavirus Infections